Week 3- RCP 110 {PFT}

Introduction to Pulmonary Function Studies (PFTs)

  • Define Pulmonary Function Studies (PFTs):

    • PFTs encompass a range of tests that assess the physiological function of the lungs.

Major Role of PFTs in Assessment of Lung Disease

  • Evaluate causes of pulmonary symptoms:

    • Dyspnea (shortness of breath)

    • Cough

    • Wheezing

    • Exercise tolerance

  • Distinguish between obstructive and restrictive lung disorders

  • Assess severity of the condition

  • Monitor trends over time to follow disease progression

  • Evaluate the effectiveness of therapy, such as bronchodilators

  • Assess patient lung function pre-operative (pre-op)

Importance of Predicted Normal Values in PFTs

  • Predicted normal values are crucial as they allow for comparison against measured values:

    • Deviations from normal predictions indicate the severity and type of lung disease.

  • Major factors influencing predicted normal values include:

    • Height

    • Age

    • Gender

    • Race

  • Height is deemed the most significant variable.

Variables Impacting Normal Values

Height

  • The most critical determinant of lung volume:

    • Taller individuals possess larger predicted lung volumes.

Weight

  • Weight's impact on lung volume is minimal unless the individual is obese:

    • Obesity can lead to smaller lung volumes.

Gender

  • Males typically exhibit larger lung volumes compared to females, assuming they are of the same height.

Age

  • Maximum lung function is generally reached by ages 20-30.

  • Healthy non-smokers without harmful exposures start to lose lung function in late 30s and 40s.

    • The trend indicates a gradual decline in lung function with advancing age.

Race

  • African Americans, Asians, and East Indians tend to have approximately 12% smaller lung volumes than Caucasians.

  • Hispanics and American Indians have moderately reduced lung volumes but do not require correction in lung volume predictions.

  • Race is considered one of the lesser factors in assessing predicted lung volumes.

Ranges for Normal PFT Values

  • Normal lung function is typically assessed between 80% to 120% of predicted values.

  • Lung function measurements are effort-dependent, requiring accurate assessment by PFT technicians who may coach patients for maximum effort during tests.

Lung Volumes and Capacities

  • Each lung volume and capacity provides specific insights into lung function:

Definitions of Lung Volumes

  • Total Lung Capacity (TLC):

    • The volume of gas in the lungs after maximal inspiration.

  • Tidal Volume (VT):

    • The volume of air inhaled and exhaled with each breath.

  • Expiratory Reserve Volume (ERV):

    • The maximum volume of air that can be exhaled from the resting end-expiratory level.

  • Residual Volume (RV):

    • The volume of air remaining in the lungs after maximal expiration regardless of starting lung volume.

  • Inspiratory Reserve Volume (IRV):

    • The volume of gas that can be inhaled after a normal inspiration, measured from a complete expiration without forced effort.

  • Vital Capacity (VC):

    • The total amount of air that can be forcibly exhaled following maximal inhalation.

  • Functional Residual Capacity (FRC):

    • The volume of air left in the lungs after a normal expiration.

Forced Expiratory Flow Rate and Volume Measurements

Forced Vital Capacity (FVC)

  • Definition:

    • The total volume of gas expelled forcefully and rapidly after a maximal inhalation.

  • Average normal FVC is approximately 4800 ml.

  • Clinical significance:

    • A decreased FVC suggests an obstructive lung disorder.

    • A normal or increased FVC points towards restrictive lung disorder.

    • A normal individual typically takes 4-6 seconds to complete exhalation during the FVC maneuver.

    • Obstructive diseases can lead to FVC being lower than VC due to increased airway resistance and air trapping despite a strong effort in administering the test.

Common Test Instruction

  • The patient should be informed, “In this test we are going to see how big your lungs are.”

  • Assess lung health via group discussion based on specific test outcomes, such as a 10-second timed exhalation (TET).

Additional Values Derived from FVC

  • Forced Expiratory Volume (FEVT):

    • This measures the maximum volume of air exhaled over specified time frames, usually recognized at intervals of 0.5, 1.0, 2.0, 3.0, and 6.0 seconds.

    • FEV1 (volume exhaled in the first second) is typically used, with a normal value being around 4200 ml (or 80% predicted or higher).

    • An FEV1 decrease indicates an obstructive lung disease while remaining normal for most restrictive disorders.

  • Percentage of total volume exhaled over time for healthy adults shows:

    • FEV0.5: 60%

    • FEV1: 80%

    • FEV2: 94%

    • FEV3: 97%

FEV1/FVC Ratio

  • Definition:

    • The FEV1/FVC Ratio compares the volume of air exhaled in 1 second to the total volume exhaled during FVC maneuver.

  • Normal findings indicate that the ratio should be ≥ 80%.

  • A ratio greater than 80% may suggest a restrictive disorder, while a ratio < 70% is often indicative of an obstructive disorder, with FEV1 determining the severity.

Clinical Application of PFT Scores

  • Factors to consider when evaluating patient pulmonary disorders:

    • Assessment of disease severity

    • Determining if the disorder is obstructive or restrictive

    • The primary differentiation based on these scores between obstructive and restrictive disorders highlights that:

    • In obstructive disorders, both FEV1 and FEV1/FVC ratio are decreased.

    • In restrictive disorders, FEV1 may be normal or increased, while the FEV1/FVC ratio is also increased.

Test Yourself Section (PFT Concepts)

  • Clinical assessments based on scenarios like pulmonary fibrosis to identify expected PFT results:

    • Understand that TLC may appear normal or larger, while expiratory flows will be decreased, implying expected findings in restrictive conditions.

Peak Expiratory Flow Rate (PEFR)

  • PEFR represents the maximum flow rate achieved during an FVC maneuver.

  • Importance:

    • Assesses large upper airway function and the degree of bronchospasm on a daily basis.

  • Measured in L/second or L/min:

    • Normal PEFR is around 10 L/second or 600 L/min.

    • A decreased PEFR indicates obstructive disease, while an increase may suggest restrictive disease.

Flow-Volume Loop

  • Description:

    • The flow-volume loop visually represents the results of both FVC and forced inspiratory volume maneuvers.

    • The upper section indicates exhalation; the lower section reflects inhalation.

  • Value extraction includes multiple metrics such as FVC, FEVT, and PEFR depending on the thoroughness of the equipment in use.

Pulmonary Diffusion Capacity

  • Carbon Monoxide (DLCO) measures the amount of carbon monoxide that diffuses across the alveolar-capillary membrane.

  • Normal DLCO averages around 25 ml/min/mmHg.

  • Clinical findings related to DLCO in different lung disorders:

    • In obstructive lung disorders, usually normal or decreased.

    • In restrictive lung conditions, the DLCO may be decreased with moderate to severe alveolar atelectasis or consolidation.

Summary of PFT Findings

  • PFTs comprise various measurements like spirometry, lung volumes, diffusion capacity, and airway resistance.

  • Normal measurements vary based on height, age, gender, and race.

  • Key distinctions:

    • Obstructive conditions demonstrate low expiratory flows.

    • Restrictive lung diseases display low lung volumes.

Review Questions

  • Identify the critical factor for predicting normal PFT values:

    • (A) Age

    • (B) Height

    • (C) Weight

    • (D) Race

  • Define total volume of air forcefully exhaled after maximal inspiration:

    • (A) MVV

    • (B) FEV1

    • (C) PEFR

    • (D) FVC

  • Determine the normal percentage of volume that can be exhaled in 1 second in a healthy adult:

    • (A) 68%

    • (B) 90%

    • (C) 80%

    • (D) 70%

  • Review obstructive disease characteristics:

    • (A) Both FEV1% and FEV1 decreased

    • (B) FVC increased

    • (C) FVC decreased with normal FEV1

    • (D) Both FEV1% and FEV1 increased

  • Identify diseases with hallmark decreased DLCO:

    • (A) Chronic Bronchitis

    • (B) Asthma

    • (C) Emphysema

    • (D) Pulmonary Edema